According to comprehensive industry analysis, the market is projected to grow from USD 1.45 billion in 2025 to USD 2.15 billion by 2032, exhibiting a CAGR of 5.1% during the forecast period.

Global Chancroid Testing market was valued at USD 78.5 million in 2024 and is projected to reach USD 112.3 million by 2032, registering a compound annual growth rate (CAGR) of 4.6% during the forecast period.

Global Intravascular Ultrasound (IVUS) market was valued at USD 375 million in 2024 and is expected to reach USD 537 million by 2032, registering a compound annual growth rate (CAGR) of 5.4% during the forecast period.

market, valued at USD 566 million in 2024, is projected to reach USD 674 million by 2031, expanding at a CAGR of 2.6% during the forecast period.

market is projected to reach USD 137 million by 2031, growing at a CAGR of 3.4% during the forecast period.

compound annual growth rate (CAGR) of 3.4% during the forecast period.

According to comprehensive industry analysis, the market is projected to rise from USD 17 million in 2024 to USD 21 million by 2030, exhibiting a CAGR of 3.3% during the forecast period.

According to comprehensive industry analysis, the market is projected to grow from USD 1.09 billion in 2025 to USD 1.69 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period.

compound annual growth rate (CAGR) of 6.4% during the forecast period.

compound annual growth rate (CAGR) of 7.9% during the forecast period.